Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of human health. We value our passion for patients, quest for innovation, spirit of independence and love of challenge. With a presence in more than 70 countries, and growing - we look for talented people to grow our business, advance our science and contribute to our unique culture.
Translational Development at Celgene
Translational Development is a department within the Research and Development organization that facilitates the transition of drug candidates from drug discovery through early- and late-stage clinical development. Early-stage translational development activities enable rational determination of dose-schedule and responsive patient populations, based on deep understanding of drug mechanism of action. Late-stage translational development activities build upon the early work, additionally exploring mechanisms of resistance, rational drug combinations and product differentiation. The late-stage translational development function is responsible for the development of translational strategies to support the development, and maximize the potential, of Celgene therapies post-clinical proof-of-concept, including registrations and life-cycle management.
Reporting to the Senior Director/Translational Development Myeloid Disease Lead, the candidate will be part of the myeloid late stage translational development group based in San Francisco, CA. The individual will be responsible for assisting with translational research strategies to build understanding of patient segments and disease biology of AML, MDS, beta-thalassemia, and myelofibrosis. The individual will also be responsible for developing, implementing and executing on lifecycle translational research strategy for a drug development program in AML and MDS, responsible for biomarker studies and analysis of patient data from ongoing clinical trials. The individual will work closely with the disease strategy team and drug program leads for early and late-stage development programs, as well as with global project teams, clinical research physicians, clinical statisticians, computational biologists, contract research organizations, academic experts, and internal translational research scientists to deliver science that supports the development and access of medicines to patients in need.
Responsibilities will include, but are not limited to, the following:
Candidate must be a rigorous scientist with a track record of effective collaboration, influential communication, and clear impact in drug development. Must be a motivated, results-oriented self-starter, who enjoys working in a fast-paced, dynamic team environment.
Skill / Knowledge Required
#LI-POSTCelgene is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Celgene complies with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must have authorization to work for Celgene in the U.S.
Not ready to apply?Join Our Talent Network
Celgene is a global biopharmaceutical company committed to improving the lives of patients worldwide. At Celgene, we seek to deliver truly innovative and life-changing treatments for our patients.